Vol 2011, No 5 (2011)

Table of Contents

Licensing

Allergan Licenses Molecular Partners’ Mid-Stage Ophthalmology Drug in US$420 M Deal Abstract
Heather Cartwright
Glenmark Pharmaceuticals Out-Licenses Anti-Inflammatory Antibody to Sanofi-aventis Abstract
Heather Cartwright

Mergers & Acquisitions

Teva Looks to Diversify its Branded Drugs Portfolio with US$6.8 B Cephalon Acquisition Abstract
Heather Cartwright
Johnson & Johnson to Acquire Synthes for US$21.3 B in Cash and Stock Abstract
Heather Cartwright
Alkermes to Purchase Elan’s Drug Delivery Unit for US$960 M in Cash and Stock Abstract
Heather Cartwright
Takeda Goes Global with US$13.7 B Nycomed Acquisition Abstract
Heather Cartwright
Teva Agrees to Acquire Taiyo to Become Key Generics Player in Japan Abstract
Heather Cartwright

Distribution & Marketing

Mundipharma Gains Commercialisation Rights to Allos Therapeutics’ Folotyn® Outside of North America Abstract
Heather Cartwright

Cartoons

Poker Game Abstract jpg
Clive Goddard


Creative Commons License
This work is licensed under a Creative Commons Attribution 3.0 License.